Invention Application
US20080026986A1 REVERSAL OF THE SUPPRESSIVE FUNCTION OF SPECIFIC T CELLS VIA TOLL-LIKE RECEPTOR 8 SIGNALING
审中-公开
特异性T细胞通过类似受体8信号的抑制功能的反转
- Patent Title: REVERSAL OF THE SUPPRESSIVE FUNCTION OF SPECIFIC T CELLS VIA TOLL-LIKE RECEPTOR 8 SIGNALING
- Patent Title (中): 特异性T细胞通过类似受体8信号的抑制功能的反转
-
Application No.: US11757235Application Date: 2007-06-01
-
Publication No.: US20080026986A1Publication Date: 2008-01-31
- Inventor: Rong-Fu Wang , Guangyong Peng , Yicheng Wang
- Applicant: Rong-Fu Wang , Guangyong Peng , Yicheng Wang
- Main IPC: A61K31/7042
- IPC: A61K31/7042 ; A61K38/02 ; A61P35/00

Abstract:
CD8+ regulatory T (Treg) cells and γδ Treg cells profoundly suppress host immune responses and thus protect against autoimmune disease while restricting desired immune responses such as antitumor immunity. Synthetic phosphorothioate-protected, guanosine-containing oligonucleotides can directly reverse the suppressive activity of Treg cells without involving dendritic cells. This effect appears to be transduced by signaling through Toll-like receptor (TLR) 8 and engagement of the MyD88 and IRAK4 molecules in Treg cells, in specific embodiments. Stimulation of Treg cells with natural ligands for human TLR8 recapitulated the effect of the synthetic guanosine-containing oligonucleotides.
Information query